Dr. Antonio Guglietta, MD
Claim this profileInvestigator Site 0810015
Area of expertise
Thrombocytopenic Purpura
Antonio Guglietta, MD has run 4 trials for Thrombocytopenic Purpura. Some of their research focus areas include:
Myasthenia Gravis
Antonio Guglietta, MD has run 4 trials for Myasthenia Gravis. Some of their research focus areas include:
Affiliated Hospitals
Investigator Site 10 - US0010088
Investigator Site 44 - US0010106
Clinical Trials Antonio Guglietta, MD is currently running
More about Antonio Guglietta, MD
Clinical Trial Related
4 years of experience running clinical trials · Led 13 trials as a Principal Investigator · 1 Active Clinical Trial
Treatments Antonio Guglietta, MD has experience with
- Efgartigimod PH20 SC
- Efgartigimod
- Placebo
- Efgartigimod PH20 SC
- Prednisone
- ARGX-117
Breakdown of trials Antonio Guglietta, MD has run
Thrombocytopenic Purpura
Myasthenia Gravis
Chronic Inflammatory Demyelinating Polyradiculoneuropathy and Multifocal Motor Neuropathy
Chronic Inflammatory Demyelinating Polyradiculoneuropathy
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Antonio Guglietta, MD specialize in?
Antonio Guglietta, MD focuses on Thrombocytopenic Purpura and Myasthenia Gravis. In particular, much of their work with Thrombocytopenic Purpura has involved corticosteroids patients, or patients who are danazol.
Is Antonio Guglietta, MD currently recruiting for clinical trials?
Yes, Antonio Guglietta, MD is currently recruiting for 1 clinical trial in Washington District of Columbia. If you're interested in participating, you should apply.
Are there any treatments that Antonio Guglietta, MD has studied deeply?
Yes, Antonio Guglietta, MD has studied treatments such as efgartigimod PH20 SC, Efgartigimod, Placebo.
What is the best way to schedule an appointment with Antonio Guglietta, MD?
Apply for one of the trials that Antonio Guglietta, MD is conducting.
What is the office address of Antonio Guglietta, MD?
The office of Antonio Guglietta, MD is located at: Investigator Site 0010045, Washington, District of Columbia 20007 United States. This is the address for their practice at the Investigator Site 0010045.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.